Study Identifies Potential Drug Target For Huntington’s Disease

Posted by john on July 31st, 2006 — in Levitra Top News

An enzyme known to be critical for the repair of damaged cells and the maintenance of cellular energy may be a useful target for new strategies to treat Huntington’s disease (HD) and other disorders characterized by low cellular energy levels. In the August issue of Chemistry & Biology, a research team from the MassGeneral Institute […]

HOW MUCH SEX?

Posted by john on July 30th, 2006 — in Levitra Top News

There are no prescribed times that a couple should engage in sexual intercourse. ‘Frequency’ really means the amount of times that both partners enjoy it.
The emphasis here is on quality of the interaction rather than quantity that may be of mediocre standard.
It is not necessary to feel a compulsion to match the amount of times […]

Reaching out to help

Posted by john on July 24th, 2006 — in Levitra Top News

For 19 year-old Danielle Millar, health insurance is not an option right now.
Millar, a local college student, works a part-time job at Kmart between classes and just can’t afford the health insurance premiums on her earnings. When she turned 18, she was disqualified from her mother’s insurance plan and has been without medical coverage since. […]

$1.4 Million Grant Helps Professor See The Light

Posted by john on July 23rd, 2006 — in Levitra Top News

http://www.mlclick.com/mlcl.php?aid=DA426DD18BE67EA4514ED9432FFC8CB1&fwd=501252.aspx
University of New Hampshire professor Rick Cote has received $1.4 million from the National Institutes of Health (NIH) to continue research into the central enzyme that controls initial steps of vision and that, when defective, can result in retinitis pigmentosa, a leading inherited cause of blindness.
Retinitis pigmentosa, or RP, affects 1.5 million people worldwide. Typically, […]

Erectile Dysfunction Internet Pitches Called Risky by FDA

Posted by john on July 19th, 2006 — in Levitra Top News

Beware the smooth-tongued Internet pitchmen touting so-called “dietary supplements” that allegedly treat erectile dysfunction and enhance sexual prowess, the FDA has warned consumers.
Specifically, the agency cited seven alleged supplements that “are in fact illegal drugs that contain potentially harmful undeclared ingredients.” The FDA warned against buying or consuming the dangerous seven, all unapproved. They are […]

Viagra Cialis and Levitra Benefit Heart and other Organs - Erectile Dysfunction ED Drugs Improve Blood Flow According to Study

Posted by john on July 15th, 2006 — in Levitra Top News

Researchers say that Viagra and other erectile dysfunction drugs benefit other systems in the body. This is according to Ernst R. Schwarz, M.D., Ph.D., a cardiologist at Cedars-Sinai Medical Center who specializes in therapies for men who suffer from erectile dysfunction (ED). Many of his patients have heart problems, diabetes, high blood […]

Tough truths about erectile dysfunction

Posted by john on July 11th, 2006 — in Levitra Top News

‘So, how are things in the bedroom?” That’s not a question that trips lightly off the tongue of most doctors when they see male patients over the age of 40. Yet, statistically, about half of those men will have some degree of erectile dysfunction (ED).
Even more importantly, trouble in bed may be an early symptom […]

Rub It Up

Posted by john on July 7th, 2006 — in Levitra Top News

Here’s an explosive piece of news. Futura Medical plc, a Guildford, Surrey, UK company, announced that it has “developed a highly efficient and proprietary delivery system for the absorption of active molecules through the skin. This delivery system is used in a gel form for MED2002, the Company’s topical treatment for men with erectile dysfunction […]

Impotency rub-on gel developed

Posted by john on July 5th, 2006 — in Levitra Top News

A rub-on gel could be the first over-the-counter treatment for impotency, a company has announced.
It is being developed by Futura Medical in collaboration with pharmaceutical giant GlaxoSmithKline.
The treatment, called MED2002, is expected to go into clinical trials at the end of 2006.
But the Sexual Dysfunction Association said it is important to await the outcome of […]

Schering-Plough, GlaxoSmithKline Study Further Validates MediSys Corporation’s MaxLife Center For Men(TM)

Posted by john on July 3rd, 2006 — in Levitra Top News

MediSys Corporation (Pink Sheets: MDYS) cited a recently published news release of a study commissioned by SCHERING-PLOUGH and GLAXO SMITH KLINE, the makers of Levitra(R), that shows a clear indication that The MaxLife Center For Men(TM) system has been — and continues to be — in the forefront of men’s health. A national survey of […]


web stats